TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE
Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered. Results of MERIT-HF study are taken as the main evidences. Patterns of the metoprolol succinate use in the treatment of different categories of patients with CHF (women, the elderly , severe CHF forms, CHF w...
Main Authors: | O. D. Ostroumova, G. N. Shchukina, V. M. Fomina |
---|---|
Format: | Article |
Language: | English |
Published: |
Stolichnaya Izdatelskaya Kompaniya
2015-12-01
|
Series: | Racionalʹnaâ Farmakoterapiâ v Kardiologii |
Subjects: | |
Online Access: | https://www.rpcardio.com/jour/article/view/636 |
Similar Items
-
Metoprolol and atenolol in mild-to-moderate chronic heart failure: The comparison of survival benefit
by: Ćelić Vera, et al.
Published: (2005-01-01) -
EFFICACY AND SAFETY OF METOPROLOL SUCCINATE IN HIGH DOSES IN PATIENTS WITH STABLE COURSE OF ISCHEMIC HEART DISEASE
by: S. N. Tolpygina, et al.
Published: (2016-01-01) -
A modern view of the place of b-blockers in the treatmentof cardiovascular disease: the choice of drug within a class is crucial
by: O D Ostroumova, et al.
Published: (2015-12-01) -
INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY
by: V. G. Tregubov, et al.
Published: (2016-01-01) -
The role of b-blockers in treatment of hypertension, according to Russian and European experts
by: O D Ostroumova, et al.
Published: (2016-03-01)